Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma

Cancer Investigation
J NemunaitisD Ando

Abstract

Melanoma is an immunoresponsive malignancy. Interleukin-10 (IL-10) is a potent regulator of immunosuppression. The purpose of this research was to define the relationship of serum IL-10 to survival in patients with metastatic melanoma. Forty-one melanoma patients and 50 normal volunteers were analyzed. The median IL-10 level as determined by enzyme-linked immunosorbent assay (ELISA) in melanoma patients was 8.75 pg/ml compared to < 3.0 pg/ml in normal volunteers (p = 0.0001). Survival of melanoma patients with an IL-10 level above 10.0 pg/ml was 365 days compared to 557 days in patients with IL-10 levels less than 10.0 pg/ml (p = 0.0259, Wilcoxon). Elevated IL-10 levels were correlated with poor survival.

References

Jun 4, 1992·Nature·A L Goldberg, K L Rock
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P PisaR Kiessling
Jul 18, 1991·The New England Journal of Medicine·H K Koh
Sep 1, 1995·Cancer Immunology, Immunotherapy : CII·E C LattimeD Berd
Nov 3, 1995·International Journal of Cancer. Journal International Du Cancer·H NakagomiR Kiessling
Apr 15, 1994·International Journal of Cancer. Journal International Du Cancer·H NakagomiM G Masucci
Mar 1, 1994·International Journal of Cancer. Journal International Du Cancer·Q ChenP Hersey
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SosmanJ Doroshow
Aug 19, 1993·International Journal of Cancer. Journal International Du Cancer·G A GastlN H Bander
Jul 1, 1996·The Journal of Experimental Medicine·H GrouxM G Roncarolo
Jul 29, 1996·International Journal of Cancer. Journal International Du Cancer·M R YoungM M Prechel
Feb 1, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·B KnoefelU Junker
Apr 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R N MainiM Feldmann
Jun 1, 1997·American Journal of Reproductive Immunology : AJRI·G ChaouatB Mognetti
Nov 21, 1997·Clinical and Experimental Immunology·T KucharzikR Stoll

❮ Previous
Next ❯

Citations

Jan 20, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S Ugurel
Jan 16, 2007·Archives of Dermatological Research·Jochen UtikalSelma Ugurel
Jan 23, 2010·Melanoma Research·Roger MouawadDavid Khayat
Jun 27, 2009·Cancer Control : Journal of the Moffitt Cancer Center·Selma UgurelJürgen C Becker
Sep 6, 2012·Leukemia & Lymphoma·Mona R HassunehPrakash S Nagarkatti
Apr 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin WeideGraham Pawelec
Jun 14, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Karolina RudnickaMagdalena Chmiela
Nov 20, 2016·Cancer Immunology, Immunotherapy : CII·Lucas Leite CunhaLaura Sterian Ward
Jul 25, 2018·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Denis LaneAlain Piché
Jun 27, 2006·Journal of Immunotherapy·María M BarrioJosé Mordoh
Oct 4, 2006·Alimentary Pharmacology & Therapeutics·C EvansD Kumar
Dec 1, 2007·Journal of Immunotherapy·Hitoe Torisu-ItakuraDonald L Morton
Jul 21, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tomonori YaguchiYutaka Kawakami
Apr 6, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ewa BienAnna Balcerska
Mar 29, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Li-Xin SunJie Lu
Sep 29, 2019·Cancer Biomarkers : Section a of Disease Markers·Alessia PaganelliRoberto Paganelli
Oct 24, 2002·Melanoma Research·J A Martínez-EscribanoM R Alvarez-López
Sep 5, 2013·Scientific Reports·Sayan Mullick ChowdhuryBalaji Sitharaman
Jan 8, 2015·Experimental Dermatology·Arlina P Wiguna, Peter Walden
Jun 14, 2020·International Journal of Clinical Practice·Bruna C BertolEduardo A Donadi
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher E TouloukianNicholas P Restifo
May 30, 2003·Pharmacological Reviews·K AsadullahH D Volk
Oct 6, 2005·Journal of Leukocyte Biology·Simone MocellinHoward A Young
Nov 14, 2007·Cancer Causes & Control : CCC·Jessica M Faupel-BadgerJoseph A Tangrea
Jul 23, 2008·Experimental Dermatology·Dan Ilkovitch, Diana M Lopez
Dec 26, 2006·Expert Review of Anticancer Therapy·Henry B Koon, Michael B Atkins
Oct 19, 2017·Cold Spring Harbor Perspectives in Biology·Xiaoting WangSascha Rutz
Aug 13, 2020·Journal of Clinical and Experimental Neuropsychology·Ruhee A PatelMadeleine E Hackney
Jan 22, 2015·Journal of Medical Genetics·Justin RendlemanTomas Kirchhoff
May 30, 2013·Annals of Dermatology·Carole Yolande PerrotAlain Mauviel
Oct 16, 2019·The Journal of Experimental Medicine·Margarida SaraivaAnne O'Garra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.